kvmcases.blogg.se - Between the lines kd williamson

We included all patients with hypertension initiating monotherapy with an ACE inhibitor or ARB between 19 across 8 databases from the United States, Germany, and South Korea. We implemented a retrospective, new-user comparative cohort design to estimate hazard ratios using techniques to minimize residual confounding and bias, specifically large-scale propensity score adjustment, empirical calibration, and full transparency. We compared the real-world effectiveness and safety of ACE inhibitors versus ARBs in the first-line treatment of hypertension.

Customer Service and Ordering InformationĪCE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs) are equally guideline-recommended first-line treatments for hypertension, yet few head-to-head studies exist.

Stroke: Vascular and Interventional Neurology.

Journal of the American Heart Association (JAHA).

Circ: Cardiovascular Quality & Outcomes.

Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).